Generic Name and Formulations:
Azelastine HCl 0.05%; oph. soln; contains benzalkonium chloride.
Indications for OPTIVAR:
Treatment of ocular itching associated with allergic conjunctivitis.
Adults and Children:
<3yrs: not recommended. ≥3yrs: 1 drop in affected eye(s) twice daily.
Contact lenses (remove; may reinsert 10 minutes after administration, if eye is not red). Pregnancy (Cat.C). Nursing mothers.
Ocular burning/stinging, headache, bitter taste, asthma, conjunctivitis, dyspnea, eye pain, fatigue, flu symptoms, transient blurred vision.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Nicotinamide and Cancer
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- Opioid Prescription Protocol Decreases Opioid Use After Gynecologic Surgery
- Everolimus Plus Letrozole May Be Active in Recurrent Endometrial Carcinoma
- Affordable Care Act Increased Percentage of Insured Patients With Gynecologic Cancers
- Everolimus Plus Letrozole: An Effective First-Line Therapy for Advanced Breast Cancer
- FDA Approves Nilotinib for Pediatric Patients With CML